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ABSTRACT
The Pancreatic Expression Database (PED, http://
www.pancreasexpression.org) continues to be a ma-
jor resource for mining pancreatic –omics data a
decade after its initial release. Here, we present
recent updates to PED and describe its evolu-
tion into a comprehensive resource for extracting,
analysing and integrating publicly available multi-
omics datasets. A new analytical module has been
implemented to run in parallel with the existing lit-
erature mining functions. This analytical module has
been created using rich data content derived from
pancreas-related specimens available through the
major data repositories (GEO, ArrayExpress) and
international initiatives (TCGA, GENIE, CCLE). Re-
searchers have access to a host of functions to tailor
analyses to meet their needs. Results are presented
using interactive graphics that allow the molecular
data to be visualized in a user-friendly manner. Fur-
thermore, researchers are provided with the means
to superimpose layers of molecular information to
gain greater insight into alterations and the relation-
ships between them. The literature-mining module
has been improved with a redesigned web appear-
ance, restructured query platforms and updated an-
notations. These updates to PED are in preparation
for its integration with the Pancreatic Cancer Re-
search Fund Tissue Bank (PCRFTB), a vital resource
of pancreas cancer tissue for researchers to support
and promote cutting-edge research.
INTRODUCTION
Pancreatic Cancer (PC) is a death sentence for most of its
patients and is projected to be one of the leading causes of
cancer-related death by 2030, second only to lung cancer
(1,2). Across the EU and US, an estimated 77% of PC pa-
tients will die within the first year of diagnosis and an esti-
mated 94% of patients will die within 5 years (3,4). A mul-
titude of studies investigated the pathogenesis of pancre-
atic malignancies and generated a huge volume of –omics
data but these findings have not yet translated into clinical
improvements. The Pancreatic Expression Database (PED)
(5–7) was developed as a data repository to provide re-
searchers with a single-entry point from which to manip-
ulate, mine and integrate these heterogeneous and isolated
findings into their own research. Although the emphasis is
on pancreatic malignancies, PED also incorporates pub-
lished findings on pancreatic precursor lesions, including
pancreatic intraepithelial neoplasias (PanINs), intraductal
papillary mucinous neoplasms (IPMNs) and mucinous cys-
tic neoplasms (MCNs), as well as benign conditions such as
chronic pancreatitis.
Since its inception in 2007, the literature mining mod-
ule of PED has been enriched through manual selection of
pancreas-related papers, followed by data curation and re-
view of the reported findings. In this release, we also offer re-
searchers the opportunity to explore experimental data via
our web-based bioinformatics infrastructure.
Manual curation of the vast volume of experimental data
available from public repositories is a time-consuming pro-
cess. As such, PED uses an automated system for data se-
lection and retrieval. This first-level data is made available
immediately to the pancreatic cancer community for explo-
ration.
Here, we present the recent release of PED, which has
novel analytical modalities, capable of analyzing and inte-
grating data generated using a range of technologies, and
an enhanced data content and query-building process. With
these additions and improvements, PED now offers an un-
precedented opportunity to explore, analyze and integrate
molecular data derived from a broad range of specimens
from tissues and body fluids of healthy people or patients,
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Figure 1. A Schematic overview of the data in the analytical module of
PED.
cell lines and mouse models, thereby expanding its utility
for pancreatic cancer research. In future, the established
framework will facilitate the integration of PED with the




PED now contains a new module for the interactive
analysis of a rich collection of publicly available multi-
omics datasets in ArrayExpress, GEO, TCGA, GENIE and
CCLE (8–12). It allows simple and efficient exploration of
those datasets to perform user-specific queries that are, for
example, not addressed or not directly discernible from the
original publications.
Automated data selection and retrieval system. We have
adopted the Smart Automatic Classification system
(SMAC, Pirrò et al., in preparation) to automate the se-
lection and prioritization (13) of relevant articles accessed
from PubMed. This is a marked departure from the previ-
ous releases of PED, where we relied on manual selection
of articles and curation of reported high-level findings.
The SMAC architecture has been expanded to identify
any molecular data generated by the studies of interest.
Where available, these associated experimental data files are
downloaded from ArrayExpress or GEO and fed into the
relevant analytical pipelines automatically. The automated
system opens up the opportunity for periodic enrichment
of our resource with minimal manual intervention.
Data content. The module is divided into four compo-
nents, named after the core data sources: PubMed, TCGA,
GENIE and CCLE. These hold expression, genomic and
mutation profiles of pancreas-related samples or cell lines.
Patient survival data is also available for a large number of
patients in the PubMed and TCGA components (Figure 1).
Analytical features. A wide range of exploratory and in-
vestigative functions have been incorporated into PED (Ta-
ble 1, see full details in the online user guide). The datasets
extracted from different sources undergo a pre-processing
workflow to ensure comparability and interoperability be-
fore being fed into the relevant analytical pipelines. For in-
stance, the normalized mRNA expression data extracted
from TCGA, CCLE and GEO/ArrayExpress undergo z-
score transformation to ensure that the data from different
studies are brought onto the same scale; the copy number
data extracted from TCGA, GENIE and CCLE are binary-
coded based on a hard threshold (2:Amplification; 1:Gain;
-1:Loss; -2:Deletion).
The exploratory features provide pre-computed results
for principal component analysis (PCA), estimation of tu-
mour purity and whole-genome view of expression or copy
number alteration events. The investigative features include
expression profiling, correlation analysis, survival analysis,
copy number analysis, mutational profiling and gene net-
work analysis, which are performed on the fly based on user-
specific query. For TCGA and CCLE datasets that contain
data generated from different technologies, an integrative
modality is made available to investigate relationships be-
tween mutations, expression and copy number changes at
single gene or whole-genome level.
Advanced visualizations. Most results are presented in an
interactive and informative graphical format using the open
source visualization library Plotly (15). The various statis-
tical and scientific charts (see Table 1) allow users to vi-
sualize the annotation of data points, zoom to focus on
area of interest, exclude/include subgroups in the data, and
download as static image files of publication quality. The
whole-genome view of expression and/or copy number data
is generated using CIRCOS software (16), which also al-
lows users to click on a particular chromosomal band to
be redirected for a detailed view of the region of interest in
the UCSC Genome Browser (17). Where applicable, results
are also presented in an interactive tabular format with fil-
tering, pagination, and sorting options, and are available for
download in multiple formats.
Improved literature mining module
The literature mining module has also been significantly up-
dated to ensure that researchers are presented with a re-
fined portal from which they can conduct intuitive biolog-
ical queries. To this end, we have i) upgraded the BioMart
data management system (18) to version 0.9 for improved
query-optimization capability, and adopted MartExplorer
GUI for intuitive query interface; ii) built a separate query
mechanisms for beginners and advanced users. With the
query interface containing fewer filters and attributes, be-
ginners can now conduct quick and simple queries, whereas
advanced users can access the original elaborate list of
filters/attributes to conduct complex queries; iii) updated
the annotations and mappings from Ensembl human gene
annotations (19) release 63 to 90 to ensure up-to-date an-
notations with GRCh38/hg38 genome assembly.
Updated documentation
We have incorporated a detailed user guide describing all
the features and functionalities in PED. The user guide for
the literature mining module has been updated to reflect all
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Table 1. An overview of the features in the analytical module of PED
Data type Analytical features
Unit of
analysis Component Description Display





Dataset    Identification of key components of




Tumour purity Dataset    Estimate tumour purity and the presence




Expression profiles Expression profile summarized across
- gene-specific Gene    - biological groups Box plot
- samples Bar plot
- whole-genome Biological
group
 Expression profile using median values of
Z-transformed expression score for each




   Pairwise correlations of genes presented
by Pearson Product Moment Correlation
Coefficients
Heatmap
Gene networks Gene(s)    Interactions between genes of interest and
their primary neighbours using human
interactome dataset from MENTHA (14),
overlaid with the expression data
summarized across the groups
Network plot
Table
Survival Survival analysis Gene   Univariate Cox proportional hazards
regression analysis to assess the









   Genomic changes using DNA copy
number of genes summarized across




   Genomic changes using the most frequent
copy number alteration events for each
gene across the genome
Frequency plot
Mutation Mutations Gene  Frequency of different mutation types









- gene-specific Gene   Integration of discrete genetic events, such
as CNA events and mutations, or relative
linear copy-number values with





  Integration of copy number alteration
events with gene expression profile across
the genome
CIRCOS plot
components of the new BioMart 0.9 query interface. An
‘Examples of use’ section is available, with practical demon-
strations of how the literature mining module can be used
for building biologically relevant queries. The user guide for
the analytics module provides an overview of the types and
sources of data, followed by an exhaustive description of the
available analytical features.
DISCUSSION AND FUTURE DIRECTIONS
Encouraged by the exponential growth of high-throughput
multi-omics pancreas-related data, this release of PED has
made the logical transition from a stand-alone data repos-
itory toward a cohesive research platform enriched with
publicly available molecular data and equipped with the
necessary analytical workflows required to conduct in-
depth explorations and tailored investigations. Such a pow-
erful combination of functionalities makes it possible to ad-
dress challenging problems quickly, such as the discovery
of non-invasive biomarkers or the identification of passen-
ger deleted genes for cancer therapeutics. For instance, the
concept of collateral lethality has recently been suggested as
a potential therapeutic strategy for pancreatic cancer (20),
focusing on the identification of co-deleted passenger genes
neighbours. Using the literature mining module of PED, re-
searchers can quickly search for homozygously co-deleted
genes proximal to TSG, and their paralogous isoforms, a
task that otherwise involves laborious data retrieval from a
number of relevant studies and considerable additional data
processing (see supplementary file 1). Furthermore, the an-
alytics module of PED allows researchers to explore those
genes in pancreas-related tissues and cancer cell lines, which
aids in pinpointing potential candidates for further valida-
tion and pharmacological testing.
The updated infrastructure of PED is a major step toward
its adoption as the bioinformatics platform of PCRFTB
(21). PCRFTB aims to create a unique resource of biologi-
cal materials and supportive clinical data from patients with
different pancreatic malignancies or from healthy donors.
PED will provide the bioinformatics platform to support
cutting-edge translational research on these samples for the
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benefit of patients. In the future, both experimental data
generated using samples obtained from the tissue bank
and the corresponding published findings will be incorpo-
rated into PED. The seamless interoperability between the
PCRFTB clinical data and PED modules will allow re-
searchers to examine those findings and analyze the molec-
ular data prior to applying for tissues, facilitating data shar-
ing and reducing duplication of efforts.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
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